Your email has been successfully added to our mailing list.

×
0 0.00543715846994542 0.00543715846994542 0.00543715846994542 -0.00273224043715841 -0.0163934426229508 -0.0751366120218579 -0.0754918032786885
Stock impact report

SELLAS Highlights Clinical Development Progress and Expected 2020 Milestones

SELLAS Life Sciences Group, Inc. (SLS) 
Last sellas life sciences group, inc. earnings: 11/14 04:41 pm Check Earnings Report
Company Research Source: GlobeNewswire
- Phase 3 Galinpepimut-S (GPS) Acute Myeloid Leukemia (AML) Study Open for Enrollment and Patient Screening Underway -              - Regulatory Feedback Regarding Nelipepimut-S (NPS) in Triple Negative Breast Cancer Expected within Q1 2020 -             - Company to Present at Biotech Showcase™ on Monday, January 13 at 9:30 a.m. PT - NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today highlighted its clinical development progress for galinpepimut-S (GPS) and nelipepimut-S (NPS) and outlined expected milestones for 2020. “We made significant clinical and corporate advances in 2019 and early this month, most notably in our preparations for our Phase 3 registrational study (REGAL study) for GPS in acute myeloid leukemia in patients who achieved complete remission Show less Read more
Impact Snapshot
Event Time:
SLS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
SLS alerts

from News Quantified
Opt-in for
SLS alerts

from News Quantified